“…kurodai has been widely studied over the years, containing a series of compounds that include polyketide macrolides, halogenated and brominated mono-and di-terpenes, brominated sesquiterpenoids, sterols, alkaloids, peptides, and others [1,2]. Aplyronines A-H (191,(290)(291)(292)(293) are polyketide macrolides found in Pacific specimens along with aplaminal (294), some of them being tested in antitumor clinical trials [46,[652][653][654][655][656]. For human HeLa-S3 cancer cells, IC 50 values were 0.5 nM for aplyronine A (191) 191) is registered at the NCI database as NSC687160, with a mean IC 50 value of~0.2 nM in the 60 cancer cell lines, but being selective against some cell lines and most active against MDR cancer cell line NCI/ADR-RES, with an IC 50 value of~0.2 nM, as well as for P388 murine leukemia, Lewis murine lung carcinoma, Erhlich murine carcinoma, colon 26 murine carcinoma, and B16 murine melanoma, but very moderated against HOP-92 (NSCLC), OVCAR-4 (ovarian cancer), TK-10 and UO-31 (renal cancers), and BT-549 and T47-D (breast cancers) [652].…”